These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 7641600
1. Cefixime. A review of its therapeutic efficacy in lower respiratory tract infections. Markham A, Brogden RN. Drugs; 1995 Jun; 49(6):1007-22. PubMed ID: 7641600 [Abstract] [Full Text] [Related]
2. Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections. Neu HC, Chick TW. Chest; 1993 Nov; 104(5):1393-9. PubMed ID: 8222794 [Abstract] [Full Text] [Related]
3. Cefixime in the treatment of patients with lower respiratory tract infections: results of US clinical trials. Quintiliani R. Clin Ther; 1996 Nov; 18(3):373-90; discussion 372. PubMed ID: 8829015 [Abstract] [Full Text] [Related]
4. Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Perry CM, Brogden RN. Drugs; 1996 Jul; 52(1):125-58. PubMed ID: 8799689 [Abstract] [Full Text] [Related]
5. Cefixime. A review of its antibacterial activity. Pharmacokinetic properties and therapeutic potential. Brogden RN, Campoli-Richards DM. Drugs; 1989 Oct; 38(4):524-50. PubMed ID: 2684593 [Abstract] [Full Text] [Related]
7. In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cefixime, in comparison with other drugs, against Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Streptococcus pneumoniae. Stefani S, Pellegrino MB, D'Amico G, Privitera A, Privitera O, Maccarrone G, Russo G, Nicoletti G. Chemotherapy; 1992 Oct; 38(1):36-45. PubMed ID: 1618002 [Abstract] [Full Text] [Related]
8. Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential. Wiseman LR, Benfield P. Drugs; 1993 Feb; 45(2):295-317. PubMed ID: 7681376 [Abstract] [Full Text] [Related]
9. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections. Perry CM, Scott LJ. Drugs; 2004 Feb; 64(13):1433-64. PubMed ID: 15212560 [Abstract] [Full Text] [Related]
10. Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections. Beumer HM. Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):30-3. PubMed ID: 2663735 [Abstract] [Full Text] [Related]
11. Comparative, multicenter studies of cefixime and amoxicillin in the treatment of respiratory tract infections. Kiani R, Johnson D, Nelson B. Am J Med; 1988 Sep 16; 85(3A):6-13. PubMed ID: 3048092 [Abstract] [Full Text] [Related]
12. Antibacterial activity of oral antibiotics against community-acquired respiratory pathogens from three European countries. Schito GC, Georgopoulos A, Prieto J. J Antimicrob Chemother; 2002 Jul 16; 50 Suppl():7-11. PubMed ID: 12077154 [Abstract] [Full Text] [Related]
15. Double-blind comparison of cefixime and cefaclor in the treatment of acute otitis media in children. Piippo T, Stefansson S, Pitkäjärvi T, Lundberg C. Scand J Infect Dis; 1991 Jul 16; 23(4):459-65. PubMed ID: 1957129 [Abstract] [Full Text] [Related]
16. Activity of FCE 22891 compared with cefuroxime axetil and cefixime in pulmonary and subcutaneous infections in mice. Rossi R, Castellani P, Younes G, Della Bruna C. J Antimicrob Chemother; 1989 Mar 16; 23 Suppl C():149-55. PubMed ID: 2732136 [Abstract] [Full Text] [Related]
18. Cefixime in the treatment of upper respiratory tract infections and otitis media. de Lalla F. Chemotherapy; 1998 Sep 16; 44 Suppl 1():19-23. PubMed ID: 9797419 [Abstract] [Full Text] [Related]
19. Overview of the clinical features of cefixime. Adam D. Chemotherapy; 1998 Sep 16; 44 Suppl 1():1-5. PubMed ID: 9797415 [Abstract] [Full Text] [Related]
20. Cefuroxime axetil: an updated review of its use in the management of bacterial infections. Scott LJ, Ormrod D, Goa KL. Drugs; 2001 Sep 16; 61(10):1455-500. PubMed ID: 11558834 [Abstract] [Full Text] [Related] Page: [Next] [New Search]